Biopharming is the process of producing (or 'farming') medicinal compounds for therapeutic use using transgenic plants or animals. This entails putting target genes into hosts (crops or animals) that would not usually express them. The desired component may be expressed in a form that may be harvested on a regular basis (e.g., milk, eggs, fruits, etc.). The use of crops for bio-production of a recombinant protein (i.e., enzyme or antibody) or a system that includes bioreactors in vitro is referred to as biopharming. In comparison to industrial expenses, this approach provides great economic and health benefits, aided by new biotechnology methods that are improving. Plant biopharming is described as the cultivation of transgenic plants that have been genetically modified to produce "humanised" medicinal compounds for human use. "Molecular farming" is another term for biopharming. Corn, soybeans, rice, tobacco, and potatoes engineered to generate a material, usually a protein, vaccines, in their fruit, leaves, seeds, or tubers, are the most popular plants now being investigated for biopharming.
Title : Study of genetic variation analysis of human TGF-A gene by RFLP Method and estimation of human DNA
Pratik Singh, Amity University Lucknow, India
Title : Protein purification and determination
Divya Yadav, Amity University Lucknow, India
Title : Study of gene expression by RT-PCR
Shazia Syed, Amity University Lucknow, India
Title : Western blotting: Analysis of protein
Misbah Arshad, Amity University Lucknow, India
Title : Study of genetic variation analysis by RFLP
Suraj Kumar Chanda, Amity University Lucknow, India
Title : Qualitative and Quantitative analysis of protein
Shruti Gupta, Amity University Lucknow, India